Seeking Alpha

CLVS
  Clovis Oncology - NASDAQ

11/26/2014, 10:37 AM ET
  • D-struction | Send Message 17 Jun

    $CLVS 43.72.
    Reply (2)
    • matratra | Send Message 17 Jun
      : It is good hold. Chart is not appealing now.
    • D-struction | Send Message 17 Jun
      : Agreed but I finally had to pull the trigger.
      CLVS vs. ETF Alternatives
      Company Description
      Clovis Oncology Inc is a biopharmaceutical company. The Company is engaged in acquiring, developing and commercializing anti-cancer treatments in the United States, Europe and other international markets.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States